特发性肺间质纤维化的药物治疗研究及新进展

Research and progression of pharmacotherapy of idiopathic pulmonary fibrosis

特发性肺间质纤维化（IPF）发病率高，药物治疗手段非常有限，预后不良。近10年来国内外学者开展了许多有关IPF药物治疗的临床研究，不断推动着IPF治疗指南的发展。现对近10年来有关IPF药物治疗的大型临床研究作一综述，介绍其研究成果及对未来的展望。

Idiopathic pulmonary fibrosis （IPF） is a kind of disease with a high incidence, very limited treatments and a poor prognosis. In the past decade, many researchers have carried out lots of clinical researches about the pharmacotherapy of IPF, promoting the development of guideline of IPF. Now, we review the clinical researches about the pharmacotherapy of IPF over the past decade, introducing its outcome and the outlook on future concept.